State of research for prostate cancer: Excerpt∗ from the report of the Prostate Cancer Progress Review Group

  • Donald J. Tindall

      Affiliations

    • Mayo Clinic, Rochester, Minnesota, USA (DJT)
    • Corresponding Author InformationReprint requests: Donald J. Tindall, PhD, Department of Urology Research, Mayo Clinic, Guggenheim 1711, 200 First St. SW, Rochester, MN 55905
  • ,
  • Peter J. Scardino

      Affiliations

    • Memorial Sloan-Kettering Cancer Center, New York, New York, USA (PJS)

Abstract 

The following is an excerpt from a report entitled: “Defeating Prostate Cancer: Crucial Directions for Research.” The report, which was submitted to the Advisory Committee to the Director of the National Cancer Institute, summarizes the findings and recommendations of the Progress Review Group.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 
  •  For the full report, see: http://osp.nci.nih.gov/prgreports/pprgreport/toc.htm

PII: S0090-4295(00)00932-8